Company intelligence / Profile preview
AEI24
- Ownership
- Private
- Development stage
- Other
Overview
AEI24 (Aragonesa De Exportacion Internacional 24 SL) is a Spanish pharmaceutical company founded in 2012 that specializes in the development, licensing, and export of over-the-counter (OTC) products, nutraceuticals, cosmetics, and medical devices. The company operates internationally with offices in Spain, Portugal, Ireland, and Brazil, exporting its portfolio to over 90 countries across five continents. AEI24's product line includes Easycol BABY+ (a lactase enzyme supplement for infant colic), Fortiferrum (liposomal iron supplements), Strippsol (fast-dissolving oral films utilizing their proprietary MultiLAY technology), and the DentYucral oral care line tailored for specific populations like diabetics and smokers. The company actively collaborates with academic institutions such as the University of Zaragoza, University of Minho, and Sapienza University of Rome to develop its healthcare solutions.
- Therapeutic areas
- PsychiatryWomen's HealthGastroenterologyDermatologyInfectious DiseasesEndocrinologyHematologyMetabolic Disorders
- Modalities
- Small moleculeRecombinant proteinBiologicDeviceBotanical extractPeptides
- Industry
- Pharma
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on AEI24.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AEI24.